Pruritus
📧 Sign up to get email alerts when something new happens for Pruritus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-05-19FDA Approved: CYPROHEPTADINE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a generic cyproheptadine hydrochloride product from Zydus Pharmaceuticals USA Inc (ANDA 208938). Indications include relief of …
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Itch Relieving Effect of Botox: a Study in Healthy Subjects [Phase 1, Phase 2]
A phase 1/2 clinical trial examines whether Botox (onabotulinumtoxinA) relieves itch in healthy subjects, with results posted in 2017.
-
CLINICAL_TRIALS research · 2017-04-27Clinical Trial Update: Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol [NA]
This clinical trial update describes an ongoing study evaluating desensitization of nociceptive afferents via topical capsaicin, trans-cinna…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405 [Phase 1]
Phase 1 study to assess mass balance recovery, metabolite profile, and metabolite identification of [14C]-SK-1405. The trial status is compl…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch [Phase 1, Phase 2]
Phase 1/2 trial evaluating high-concentration topical capsaicin for reducing pruritus; study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-11-08FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for hydroxyzine hydrochloride from Chartwell RX, LLC, authorizing a generic version under ANDA04…
-
FDA approval · 2016-11-08FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for hydroxyzine hydrochloride by Chartwell RX, LLC.
-
FDA approval · 2016-11-08FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for hydroxyzine hydrochloride, confirming approval of an additional submission for this generic…
-
FDA approval · 2016-11-08FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental ANDA for hydroxyzine hydrochloride by Amneal Pharmaceuticals LLC, authorizing the generic product under the appr…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus [Phase 2]
Phase 2 study evaluating safety, pharmacokinetics, and preliminary efficacy of intravenous CR845 (difelikefalin) in hemodialysis patients wi…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: The Effect and Safety of Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia Patients [Phase 2, Phase 3]
This trial update reports on a Phase 2/3 study evaluating the effects and safety of hemodialysis and hemoperfusion on renal osteodystrophy a…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects [Phase 1]
Phase 1 study evaluating receptor occupancy of SK-1405 in healthy, Caucasian, male subjects to explore pharmacodynamics related to pruritus;…
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydroxyzine hydrochloride by Teva Pharmaceuticals USA, Inc., under ANDA088617.
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for hydroxyzine hydrochloride (HYDROXYZINE HYDROCHLORIDE) from Chartwell RX, LLC. This approval allo…
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (American Regent, Inc.)
The FDA approved a supplemental application for hydroxyzine hydrochloride from American Regent, Inc., finalizing an update to the generic pr…
-
FDA approval · 2016-03-30FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for hydroxyzine hydrochloride (generic) from Aurobindo Pharma Limited, expanding approval of a gener…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus [Phase 2]
A Phase 2 clinical trial evaluating the effects of Fumaria parviflora L. on pruritus in patients with end-stage renal disease has completed.
-
CLINICAL_TRIALS research · 2016-01-12Clinical Trial Update: L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain [NA]
A clinical trial evaluating L-menthol as a topical counter-irritant to TRPA1-induced neurogenic inflammation and pain has completed. The stu…
-
CLINICAL_TRIALS research · 2015-10-09Clinical Trial Update: The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial [NA]
A randomized controlled trial evaluating botulinum toxin for itching associated with hypertrophic scars; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Comparison of Epidural Oxycodone and Epidural Morphine [Phase 3]
A completed Phase 3 trial comparing epidural oxycodone with epidural morphine in patients experiencing pruritus.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P [Phase 1]
Phase 1 trial assessing itch control with VLY-686 in healthy volunteers after intradermal injections of Substance P has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis [NA]
This clinical trial update assesses the efficacy of laser acupuncture for reducing pruritus in patients with chronic kidney disease who are …
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)
This clinical trial update describes observational usage of Loratadine (Claritin) in pediatric patients using tablet, RediTabs, and dry syru…
-
CLINICAL_TRIALS withdrawal · 2015-01-27Clinical Trial Update: Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
A Boston University–sponsored Merck study evaluating vorinostat for pruritus signaling pathways has been withdrawn.
-
FDA approval · 2015-01-24FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva’s supplemental application for hydroxyzine pamoate, confirming its status as an approved generic drug. The action rela…